Kochanski & Partners has advised VC fund Inovo Venture Partners on its investment in Jutro Medical. Most Partners reportedly advised Jutro Medical.
The transaction was made in a seed round, with Inovo as the lead investor, and with other investors including Rheingau Founders, Market One Capital, and business angels.
According to Kochanski & Partners, Inovo Venture Partners is a venture capital fund supporting technology companies in Poland and Central and Eastern Europe. Through its two funds, Inovo manages assets with a total value of PLN 275 million, with its portfolio currently consisting of 16 companies, including Booksy, Spacelift, Infermedica, and SunRoof. Jutro Medical has been in the fund’s portfolio since late 2020. As a result of the deal, Inovo has significantly increased its stake in the company, with Jutro Medical becoming its largest investment to date.
"The COVID-19 pandemic has accelerated the development of advanced medical services, fusing high quality with convenience and ease of contact," commented Pawel Mardas, Partner and Head of M&A at Kochanski & Partners. "Jutro Medical provides rapid access to quality healthcare, from the comfort of your own home. This is yet another transaction by the Inovo fund in the medtech sector, demonstrating the growing interest in investing in this market segment."
Earlier this year, Kochanski & Partners advised Inovo on the acquisition of shares in technology company SunRoof (as reported by CEE Legal Matters on May 4, 2021).
The Kochanski & Partners team was led by Mardas and included Head of Transaction Advisory and Analysis Szymon Balcerzak, Counsel Piotr Galka, Senior Associate Anna Golenia, and Associate Tomasz Szambelan.